Aug. 8, 2023

 

The American College of Radiology® (ACR®), American College of Emergency Physicians (ACEP) and American Society of Anesthesiologists (ASA) applaud the Aug. 3 U.S. District Court for the Eastern District of Texas’ ruling that the government's exorbitant 600% fee increase to access the independent dispute resolution (IDR) process and its overly restrictive “batching” limitations violate federal law. The ruling does not impact the patient protections included in the No Surprises Act, which ACR, ACEP and ASA advocated for and continue to support, nor does it raise patient out-of-pocket costs.

The court agreed with plaintiffs — the Texas Medical Association (TMA), the Texas Radiological Society and Houston Radiology Associated — that the government wrongly raised the fees to participate in the IDR process established to resolve out-of-network care billing disputes, and restricted providers’ ability to submit claims for similar services in “batches” without giving providers advance notice and an opportunity to comment.

ACR, ACEP and ASA filed a joint amicus brief with the Texas court showing how fee guidance published Dec. 23 by the Centers for Medicare and Medicaid Services (CMS) is unworkable. Effective Jan. 1, 2023, CMS increased the non-refundable administrative fee to contest disputed insurer reimbursement from $50 to $350. This drastic increase precludes many providers — particularly radiologists — from participating as their billed services are routinely less than $350.

In addition, interim final rules (IFR) published in October 2021 unreasonably limit the batching of claims for the IDR process to the same or similar service codes. This means that only claims for the same code billed to the same insurance plan within a 30-day period may be batched, further limiting IDR access.

Physicians, who are forced to utilize the IDR process because of unreasonable insurance payments, are prevailing in the arbitrators’ decisions more than 70% of the time. The court’s ruling is an important step in ensuring that the dispute resolution system is accessible and fair, as envisioned by the law’s authors.

Notably, the government has suspended the IDR process, effective immediately, because of this latest court decision. CMS termed this as an “Unplanned Outage.” Physicians now must await further government guidance on how to submit claims under the IDR process for reimbursement of services.

ACR, ACEP and ASA stand ready to work with the federal government, patient groups and other stakeholders to find solutions that ensure a fair IDR process for out-of-network care payment that is sufficiently accessible, can ease growing case backlogs and will help safeguard patient access to care.

The Texas case solely impacts the IDR process to determine provider payment for out-of-network care.


Recent ACR Press Releases

  • American College of Radiology Launches First Medical Practice Artificial Intelligence Quality Assurance Program

    The American College of Radiology® (ACR®) today launched the ACR Recognized Center for Healthcare-AI (ARCH-AI), the first national artificial intelligence quality assurance program for radiology facilities.

    Read more
  • National Medical Groups Express Growing Concern Over HHS Extended Closure of Arbitration Process

    As the No Surprises Act’s Independent Dispute Resolution (IDR) portal surpasses the 8-week mark since its halt of full operations for the filing of new IDRs, the American College of Emergency Physicians, American College of Radiology®, American Society for Anesthesiology, the Emergency Department Practice Management Association and Radiology Business Management Association together urged the U.S. Department of Health and Human Services to reopen the national portal.

    Read more
  • ARPA-H appoints Pisano to lead Advancing Clinical Trials Readiness Initiative

    The Advanced Research Projects Agency for Health (ARPA-H) has appointed American College of Radiology® (ACR®) Chief Research Officer (CRO) Etta D. Pisano, MD, FACR, senior portfolio lead, to build the agency’s clinical trial portfolio and lead the ARPA-H Advancing Clinical Trials Readiness Initiative under ARPA-H Resilient Systems Mission Office Director Jennifer Roberts.

    Read more